Navigation Links
Groundbreaking First Response Spray Now Available in Europe
Date:4/15/2009

Solution Provides 99.99 Percent Reduction of Many Dangerous Pathogens

UNION, Ky., April 15 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC today announces the European distribution of its flagship product, MyClyns, a portable spray that reduces 99.99 percent of many harmful pathogens and helps prevent infection. European first responders and public safety officials will now have access to the spray, which is a critical component to effective, portable protection.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090415/CL99689 )

MyClyns is available from a number of distributors throughout Europe.

After coming into contact with bodily fluids from a potentially infected person, first responders can quickly and easily spray MyClyns in their eyes, mouth or on other points of contact. Response time is critical to lower the chances of becoming infected after an exposure, and MyClyns offers immediate protection.

The pocket-sized units contain a powerful solution that has been found to reduce 99.99 percent of HIV-1, Hepatitis C, MRSA, TB, and 60 pathogens in independent laboratory testing. The spray is alcohol-free and proven safe for use on all mucous membranes, including the eyes, ears, nose, and mouth.

"MyClyns has found significant success within the public safety sector, as first responders are frequently exposed to the dangers of bodily fluids and other harmful pathogens," says Union Springs Pharmaceuticals president Joel Ivers. "The expansion of this product into European markets is in response to the need for personal protection anywhere in the world where public safety officials risk dangerous exposure."

The spray has already proven to be an asset to public safety officials, military, corrections, and EMS in the United States and Canada.

New Orleans EMS Deputy Director Carl Flores agrees. "One of our employees had a combative patient who was HIV positive spit in his face," said Flores. "He used MyClyns and felt better knowing it was readily available for this incident. As a manager, I cannot tell you how pleased I am to provide our employees with this added layer of protection and sense of confidence when they needed it most."

Visit www.myclyns.eu for more information about the product.

About Union Springs Pharmaceuticals, LLC

Union Springs Pharmaceuticals, LLC specializes in providing innovative infection control products for the EMS, fire, law enforcement, corrections, military, government, healthcare, and consumer markets. Union Springs Pharmaceuticals offers personal and environmental exposure response products including MyClyns, the revolutionary personal protection spray that can be applied into the eyes, nose, and mouth. Union Springs also offers the T-5000 and T-5000V P95 respirators, the only disposable respirators with antibacterial and antiviral technology. More information on Union Springs Pharmaceuticals and its products can be found at www.uspharma.com.


'/>"/>
SOURCE Union Springs Pharmaceuticals, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
2. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign
3. Details of Oregon Wine Regions First Luxury Inn, Spa Revealed at Groundbreaking Ceremony
4. UC-Irvine scientists present groundbreaking research at Society for Neuroscience conference
5. Groundbreaking Apo E Gene Diet Linked to Alzheimers Disease and Heart Disease Prevention
6. SIRIUS Satellite Radio to Launch Doctor Radio, a Groundbreaking, 24/7 Health and Wellness Channel, in Partnership With NYU Medical Center
7. Discovery Health Travels the World to Present the Groundbreaking Documentary - Diabetes: A Global Epidemic
8. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
9. Groundbreaking Study Reveals How Consumers Shop for Health Care
10. California Institute of Integral Studies Launches Groundbreaking Community Mental Health Program
11. CleanRest(R) Announces a Groundbreaking Invention, The Worlds Cleanest Pillow(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... CA (PRWEB) , ... February 23, 2017 , ... CALNOC, ... FACP, FACMPE, FACPE, will keynote their upcoming conference – Empowerment, Value and Collaboration – ... the chairman and CEO of the Virginia Mason Health System in Seattle since 2000. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that ... of CM-AT in children aged 3-8 with Autism, is now enrolling at three new ... children across the United States. , “There are currently no approved drugs that ...
(Date:2/23/2017)... ... ... Thomas Vas-Don suffered from severe injury due to an ... successfully recover. In “ Origin & Insertion Charts for Massage Therapists ” (published by ... massage, anatomy , trigger points and referral pain patterns . , In ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... and lobby of a new healthcare contact center in Georgia, PENETRON Specialty Products ... of the nation’s largest healthcare systems recently invested $51 million to purchase and ...
(Date:2/22/2017)... Raton, FL (PRWEB) , ... February 22, 2017 , ... ... primarily from deer antler velvet, announced its products are coming soon to Amazon.com, the ... Clint and Shelley Thomson as a means to develop an effective natural treatment for ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... February 23, 2017 Persistence ... the global market for intraoperative imaging, excerpts from ... at US$ 513.9 million. According to the report, ... on the grounds of increasing adoption of minimally-invasive ... of diagnostic imaging for neurosurgeries. The world,s leading ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Prosthetic Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 9.2% over the next ... industry report analyzes the market estimates and forecasts for all the ...
(Date:2/23/2017)... , Feb. 23, 2017 MabVax ... oncology drug development company, announces that it has ... Administration (FDA) authorizing the initiation a Phase I ... for pancreatic cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is ... MabVax plans to initiate the phase I clinical ...
Breaking Medicine Technology: